These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 15176235
21. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240 [Abstract] [Full Text] [Related]
22. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea. Peled N, Pitlik S, Samra Z, Kazakov A, Bloch Y, Bishara J. Infect Control Hosp Epidemiol; 2007 Apr; 28(4):377-81. PubMed ID: 17385141 [Abstract] [Full Text] [Related]
23. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. Snell H, Ramos M, Longo S, John M, Hussain Z. J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364 [Abstract] [Full Text] [Related]
24. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay]. Nurzyńska G, Pituch H, Kamola R, Kopeć ES. Med Dosw Mikrobiol; 2013 Oct; 65(4):263-8. PubMed ID: 24730214 [Abstract] [Full Text] [Related]
25. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors]. Tunçcan OG, Ulutan F, Karakuş R. Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078 [Abstract] [Full Text] [Related]
26. [Comparison of AP-PCR methods, ribotyping (PCR-ribotyping) and pulsed-field electrophoresis (PFGE) for strains of Clostridium difficile producing toxin B and not producing toxin A]. Pituch H, van Belkum A, Obuch-Woszczatyński P, Meisel-Mikołajczyk F, Łuczak M. Med Dosw Mikrobiol; 2003 Oct; 55(1):53-60. PubMed ID: 12908415 [Abstract] [Full Text] [Related]
27. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. al-Barrak A, Embil J, Dyck B, Olekson K, Nicoll D, Alfa M, Kabani A. Can Commun Dis Rep; 1999 Apr 01; 25(7):65-9. PubMed ID: 10344088 [No Abstract] [Full Text] [Related]
28. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina]. Fernandez Canigia L, Nazar J, Arce M, Dadamio J, Smayevsky J, Bianchini H. Rev Argent Microbiol; 2001 Apr 01; 33(2):101-7. PubMed ID: 11494752 [Abstract] [Full Text] [Related]
29. [Clostridium difficile and diarrhea associated with the use of antibiotics in the origin of nosocomial and community-acquired diarrhea]. Knobel H, Salvado M, Segura C. Enferm Infecc Microbiol Clin; 1996 Feb 01; 14(2):96-100. PubMed ID: 8714156 [Abstract] [Full Text] [Related]
30. Positive predictive value of the immunoassay for Clostridium difficile toxin A and B detection at a private hospital. Pérez-Topete SE, Miranda-Aquino T, Hernández-Portales JA. Rev Gastroenterol Mex; 2016 Feb 01; 81(4):190-194. PubMed ID: 27316592 [Abstract] [Full Text] [Related]
31. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates. De Barbeyrac B, Guinet R, Quentin C, Cantet P, Bebear C. Ann Biol Clin (Paris); 1989 Feb 01; 47(2):67-70. PubMed ID: 2660635 [Abstract] [Full Text] [Related]